Clinical trial : hepatitis B virus genotype and a combination of end‐of‐treatment biomarkers predict severe flares after nucleos(t)ide analogue cessation
Bron
Alimentary pharmacology and therapeutics - ISSN 0269-2813- (2025) p. 1-10
Persistent risk of hepatocellular carcinoma despite improvement of liver stiffness in patients with chronic HBV with advanced fibrosis
Bron
JHEP Reports - ISSN 2589-5559-7:11 (2025) p. 1-9
Severe liver‐related outcomes in patients with hepatitis delta : results from a multi‐ethnic multicenter long‐term follow‐up study
Bron
Journal of viral hepatitis - ISSN 1352-0504-32:2 (2025) p. 1-15
Predictors of hepatic flares after nucleos(t)ide analogue cessation : results of a global cohort study (RETRACT-B study)
Bron
Journal of hepatology - ISSN 0168-8278-82:3 (2025) p. 446-455
Limited sustained remission after nucleos(t)ide analog withdrawal : results from a large, global, multiethnic cohort of patients with chronic hepatitis B (RETRACT-B Study)
Bron
The American journal of gastroenterology - ISSN 0002-9270-119:9 (2024) p. 1849-1856